Get access to our best features

Get access to our best features

Pfizer's Paxlovid not included in China's national insurance

Summary by CTV News
China's health care authorities declined to include Pfizer's COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price throughout the country, saying it was too expensive.
Published 5 months ago · Beijing, China

News Articles

More Filters
All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

45% of the sources lean Left
Associated Press News
abc News
Bloomberg
Alaska Highway News
Times Colonist
Lakeland Today
+10
Reuters
CTV News
South China Morning Post
KIFI
Channel News Asia
Star Advertiser
+9
National Post
MY Northwest
연합뉴스-Yonhap News Agency
The National Herald
L 46%
C 42%
12%
See less detail